Target polar interaction with ligand

In early discovery, new chemical entities of interest can be either polar compounds (e.g., peptides, nucleotides, sugars) or non-polar compounds (e.g., ligands or inhibitors maximizing hydrophobic interactions with therapeutic targets). Thus ideal HTS in vitro methods must be able to cover a large range of lipophiiicity values. This goal... 

---